Boris Kin Lin
age ~62
from Zionsville, IN
- Also known as:
-
- Boris K Lin
- Boris J Lin
- Kin Boris Lin
- Boris K Kin
- Lin K Boris
- Phone and address:
-
8885 Sandstone Pl, Zionsville, IN 46077
(317)3971838
Boris Lin Phones & Addresses
- 8885 Sandstone Pl, Zionsville, IN 46077 • (317)3971838
- 5401 Graceland Ave, Indianapolis, IN 46208 • (617)5248872
- 1032 N New Jersey St, Indianapolis, IN 46202 • (317)9178584
- 1032 N New Jersey St #1, Indianapolis, IN 46202 • (317)9178584
- 350 Arborway, Jamaica Plain, MA 02130 • (617)5248872
- 350 Arborway #2 2, Jamaica Plain, MA 02130 • (617)7612733
- 5324 S Hyde Park Blvd, Chicago, IL 60615 • (312)3635907
- 5324 S Hyde Park Blvd #3, Chicago, IL 60615 • (312)7612733
- Staten Island, NY
Education
-
School / High School:U Of Chgo Div Of Bio Sci Pritzker Sch Of Med1991
Languages
English
Awards
Healthgrades Honor Roll
Ranks
-
Certificate:Internal Medicine, 1998
Specialities
Internal Medicine
Name / Title
Company / Classification
Phones & Addresses
Boris Lin MD
Internist
Internist
8885 Sandstone Pl, Zionsville, IN 46077
Medicine Doctors
Dr. Boris K Lin, Zionsville IN - MD (Doctor of Medicine)
view sourceSpecialties:
Internal Medicine
Address:
8885 Sandstone Pl, Zionsville, IN 46077
Certifications:
Internal Medicine, 1998
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
Graduated: 1991
Medical School
Beth Israel Deaconess Medical Center
Graduated: 1991
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
Graduated: 1991
Medical School
Beth Israel Deaconess Medical Center
Graduated: 1991
Boris Kin Lin
view sourceSpecialties:
Internal Medicine
Hematology & Oncology
Medical Oncology
Hematology & Oncology
Medical Oncology
Education:
University of Chicago (1995)
Resumes
Senior Medical Director- Selpercatinib Product Team
view sourceLocation:
Greenwood, IN
Industry:
Research
Work:
Eli Lilly and Company
Senior Medical Director- Selpercatinib Product Team
Dana-Farber Cancer Institute 1998 - 2002
Research Fellow
Tufts Medical Center 1998 - 2002
Hematology Oncology Fellow
Senior Medical Director- Selpercatinib Product Team
Dana-Farber Cancer Institute 1998 - 2002
Research Fellow
Tufts Medical Center 1998 - 2002
Hematology Oncology Fellow
Education:
University of Chicago 1987 - 1995
Doctor of Medicine, Doctorates, Doctor of Philosophy, Molecular Biology, Biochemistry, Medicine The Johns Hopkins University 1981 - 1984
Bachelors, Bachelor of Arts, Biology
Doctor of Medicine, Doctorates, Doctor of Philosophy, Molecular Biology, Biochemistry, Medicine The Johns Hopkins University 1981 - 1984
Bachelors, Bachelor of Arts, Biology
Skills:
Oncology
Clinical Trials
Clinical Development
Pharmaceutical Industry
Clinical Research
Medical Affairs
Medicine
Hematology
Cancer
Drug Development
Biotechnology
Medical Writing
Neuroscience
Immunology
Life Sciences
Ctms
Gcp
Pharmacovigilance
Regulatory Submissions
Drug Discovery
Cro
Infectious Diseases
Clinical Pharmacology
Translational Medicine
Pharmacology
Biopharmaceuticals
Therapeutic Areas
Biomarkers
Lifesciences
Translational Research
Medical Education
Clinical Trials
Clinical Development
Pharmaceutical Industry
Clinical Research
Medical Affairs
Medicine
Hematology
Cancer
Drug Development
Biotechnology
Medical Writing
Neuroscience
Immunology
Life Sciences
Ctms
Gcp
Pharmacovigilance
Regulatory Submissions
Drug Discovery
Cro
Infectious Diseases
Clinical Pharmacology
Translational Medicine
Pharmacology
Biopharmaceuticals
Therapeutic Areas
Biomarkers
Lifesciences
Translational Research
Medical Education
Boris Lin
view sourceUs Patents
-
Epothilone Derivatives For The Treatment Of Multiple Myeloma
view source -
US Patent:20090233973, Sep 17, 2009
-
Filed:May 29, 2009
-
Appl. No.:12/474555
-
Inventors:Boris Lin - Indianapolis IN, US
Kenneth C. Anderson - Wellesley MA, US
James Douglas Griffin - Brookline MA, US -
International Classification:A61K 31/427
A61P 35/00 -
US Classification:514365
-
Abstract:The present invention relates to a method of treating a warm-blooded animal, especially a human, having myeloma, especially myeloma which is resistant to conventional cytotoxic chemotherapy, comprising administering to said animal a therapeutically effective amount of an epothilone, especially an epothilone of formula Ito a combination comprising an epothilone, for simultaneous, separate or sequential use; and to a pharmaceutical composition and a commercial package comprising said combination.
-
Epothilone Derivatives For The Treatment Of Multiple Myeloma
view source -
US Patent:20060094766, May 4, 2006
-
Filed:Oct 10, 2003
-
Appl. No.:10/530857
-
Inventors:Boris Lin - Indianapolis IN, US
Kenneth Anderson - Wellesley MA, US
James Griffin - Brookline MA, US -
International Classification:A61K 31/427
-
US Classification:514365000
-
Abstract:The present invention relates to a method of treating a warm-blooded animal, especially a human, having myeloma, especially myeloma which is resistant to conventional cytotoxic chemotherapy, comprising administering to said animal a therapeutically effective amount of an epothilone, especially an epothilone of formula I to a combination comprising an epothilone, for simultaneous, separate or sequential use; and to a pharmaceutical composition and a commercial package comprising said combination.
Boris Lin Boris Lin
view source
Boris Lin Lin
view source
Boris Lin
view source
Boris Lin
view source
Boris Lin Mvogo
view source
Boris Lin
view source
Boris Lin
view source
Boris Lin
view sourceYoutube
Googleplus
Boris Lin
Boris Lin
Boris Lin
Boris Lin
Boris Lin
Boris Lin
Boris Lin
Boris Lin
Get Report for Boris Kin Lin from Zionsville, IN, age ~62